{"transactions":[{"id":803127,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-04-22T16:18:28.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":37100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 20, 2026 (the \"Grant Date\"), the Reporting Person was granted stock options to purchase 37,100 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date."}],"balance_after":37100,"derivative":{"exercise_price":2.36,"expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":37100},"source":{"system":"sec-edgar","filing":"0001104659-26-046836","document":"tm2612397-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465926046836/tm2612397-3_4seq1.xml","form_type":"4"}},{"id":1280573,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-06T17:45:47.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2025, the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest immediately."}],"balance_after":250000,"derivative":{"exercise_price":0.7982,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-25-010179","document":"tm255798-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465925010179/tm255798-1_4seq1.xml","form_type":"4"}},{"id":1307050,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants for Common Stock","published_at":"2025-01-08T16:30:38.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":49261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock."}],"balance_after":49261,"derivative":{"exercise_price":0.9,"exercise_date":"2025-01-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":49261},"source":{"system":"sec-edgar","filing":"0001104659-25-002050","document":"tm252665-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465925002050/tm252665-2_4seq1.xml","form_type":"4"}},{"id":1307049,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T16:30:38.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":49261,"price":1.015,"value":49999.915,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc."}],"balance_after":1010196,"source":{"system":"sec-edgar","filing":"0001104659-25-002050","document":"tm252665-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465925002050/tm252665-2_4seq1.xml","form_type":"4"}},{"id":1550724,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2024-04-03T21:55:50.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2024 (the \"Grant Date\"), the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":3.15,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-24-043291","document":"tm2411025-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924043291/tm2411025-1_4seq1.xml","form_type":"4"}},{"id":1688610,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants for Common Stock","published_at":"2024-01-04T16:26:24.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":false,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-24-001375","document":"tm242052-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924001375/tm242052-2_4seq1.xml","form_type":"4"}},{"id":1688609,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T16:26:24.000Z","date":"2024-01-03","kind":"exercise","planned":false,"acquired":true,"shares":19737,"price":3.55,"value":70066.35,"ownership":{"direct":true},"balance_after":960935,"source":{"system":"sec-edgar","filing":"0001104659-24-001375","document":"tm242052-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924001375/tm242052-2_4seq1.xml","form_type":"4"}},{"id":1688608,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T16:26:24.000Z","date":"2023-12-22","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":941198,"source":{"system":"sec-edgar","filing":"0001104659-24-001375","document":"tm242052-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924001375/tm242052-2_4seq1.xml","form_type":"4"}},{"id":1688607,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T16:26:24.000Z","date":"2023-12-12","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":971198,"source":{"system":"sec-edgar","filing":"0001104659-24-001375","document":"tm242052-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924001375/tm242052-2_4seq1.xml","form_type":"4"}},{"id":1688606,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T16:26:24.000Z","date":"2021-12-02","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":1011198,"source":{"system":"sec-edgar","filing":"0001104659-24-001375","document":"tm242052-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465924001375/tm242052-2_4seq1.xml","form_type":"4"}},{"id":1993783,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-02-24T16:30:38.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 13, 2023 (the \" Grant Date\"), the Reporting Person was granted stock options to purchase 130,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":130000,"derivative":{"exercise_price":3.41,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001104659-23-025330","document":"tm237745-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465923025330/tm237745-1_4seq1.xml","form_type":"4"}},{"id":2200422,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants for Common Stock","published_at":"2022-07-29T17:02:07.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19737,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2028-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-22-084316","document":"tm2222169-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465922084316/tm2222169-2_4seq1.xml","form_type":"4"}},{"id":2200421,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants for Common Stock","published_at":"2022-07-29T17:02:07.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19737,"derivative":{"exercise_price":3.55,"exercise_date":"2023-01-27","expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":19737},"source":{"system":"sec-edgar","filing":"0001104659-22-084316","document":"tm2222169-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465922084316/tm2222169-2_4seq1.xml","form_type":"4"}},{"id":2200420,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-29T17:02:07.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":19737,"price":3.8,"value":75000.6,"ownership":{"direct":true},"balance_after":1051198,"source":{"system":"sec-edgar","filing":"0001104659-22-084316","document":"tm2222169-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465922084316/tm2222169-2_4seq1.xml","form_type":"4"}},{"id":2501239,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-22T16:05:53.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":5034,"price":4.901,"value":24671.634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price."}],"balance_after":1031461,"source":{"system":"sec-edgar","filing":"0001104659-21-142473","document":"tm2133703-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465921142473/tm2133703-2_4seq1.xml","form_type":"4"}},{"id":2641749,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2021-07-06T16:05:40.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 1, 2021 (the \"Employment Agreement Grant Date\"), the Reporting Person was granted stock options to purchase 500,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's Executive Chairman pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024."}],"balance_after":500000,"derivative":{"exercise_price":6.18,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-21-089392","document":"tm2121425-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465921089392/tm2121425-1_4seq1.xml","form_type":"4"}},{"id":2641748,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2021-07-06T16:05:40.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 29, 2021 (the \"June Grant Date\"), the Reporting Person was granted stock options to purchase 350,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":350000,"derivative":{"exercise_price":6.26,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001104659-21-089392","document":"tm2121425-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000110465921089392/tm2121425-1_4seq1.xml","form_type":"4"}},{"id":4348833,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":51674,"kind":"person","name":"DELUCCIA ROBERT J","position":1,"cik":"0001127423","reported_name":"DELUCCIA ROBERT J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options","published_at":"2017-04-20T06:15:54.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":183332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest as follows: options to purchase 91,666 shares of common stock vested on January 17, 2017; options to purchase 3,819 shares of common stock vest monthly in each of the 23 months after the date of grant and options to purchase 3,829 shares of common stock will vest on the 24th month anniversary of the date of grant."}],"balance_after":183332,"derivative":{"exercise_price":1.8,"expiration_date":"2022-01-17","underlying":"Common Stock","underlying_shares":183332},"source":{"system":"sec-edgar","filing":"0001144204-17-021120","document":"v464463_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127423/000114420417021120/v464463_4.xml","form_type":"4"}}]}